My site

Dubai, United Arab Emirates-Tuesday 19 May 2020 [ AETOS Wire ]

Leading Global Forex Brokerage firm, Axiory Global Ltd  is all set to enter a new era in oil trading with two brand new products that have been especially designed to combat negative oil prices: the US Oil Index and the UK Oil Index. Last month saw a historic crash when West Texas Intermediate (WTI) crude oil, May futures contracts, dropped below $0 for the first time ever. As a result, Axiory Global sprang into action by disabling trading on WTI owing to exceptionally high volatility and adding Brent Crude Oil to its assets.

The US Oil Index and the UK Oil Index are rebased at $100, which means that even if the price of oil drops into negative territory, the indices will remain $100 higher. For example, if Brent oil drops to $-5, the UK Oil Index will trade it at $95.

Both products are independent tradable instruments, but their price movements are linked to the movement of oil prices + $100 ... Read more »

Advanced Geospatial Technology Will Be Provided during Pandemic

REDLANDS, Calif.-Tuesday 19 May 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- Esri, the global leader in location intelligence, today announced that it has partnered with the Inter-American Development Bank (IDB) to provide free access to geospatial technology in response to the COVID-19 emergency in Latin America and the Caribbean (LAC). Governments in the region will be able to use a COVID-19 solution to track critical equipment and asset availability, manage supply chains, and maintain business continuity.

Leveraging Esri’s Disaster Response Program, and based on the specific needs of IDB member countries, this collaboration provides access to technology resources that can enhance the region’s response to the immediate public health emergency posed by COVID-19. Concretely, governments in the region will be able to leverage Esri’s analytical models and implement dashboards and contro ... Read more »

Massive Mutual Fund Availability at Low or No Cost to Citizens Worldwide

GREENWICH, Conn.-Tuesday 19 May 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- Interactive Brokers Group, Inc. (Nasdaq:IBKR) today announced the launch of its new Mutual Fund Marketplace, which offers availability to more than 25,000 mutual funds, including over 21,000 no load and 8,300 no transaction fee funds, from more than 290 fund families. The marketplace, which can be visited at ibkr.com/funds, is available to residents in over 200 countries and territories.

“The Interactive Brokers Mutual Fund Marketplace is now the largest, single source of no-load mutual funds,” said Steve Sanders, EVP of marketing and product development. “Our marketplace also has lower costs, if not the lowest, on our massive inventory of mutual funds.”

Clients can select from thousands of free mutual funds or pay just € 4.95 (or equivalent) per trade.** Sanders also noted that, u ... Read more »

MINNEAPOLIS-Thursday 14 May 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Smiths Medical, a leading global medical device manufacturer, announces today the acquisition of the business of Access Scientific, LLC, a privately-held company based in San Diego, CA. Access Scientific is a broad-spectrum vascular access and infection prevention company that manufactures the POWERWAND™ midline and extended dwell catheters. The range of POWERWAND™ products extends Smiths Medical’s vascular access product portfolio and enables greater clinician choice to treat patients.

The POWERWAND™ range of products are clinically differentiated vascular access solutions, supported by nine (9) peer-reviewed papers and nine (9) scientific posters. Bloodstream infections are a known risk associated with vascular access catheters. Conclusions from recent clinical studies show no occurrence of bloodstream infections associated with use of the POWERWAND™ products. Combined, ... Read more »

ST GALLEN, Switzerland & MOUNTAIN VIEW, Calif. -Monday 18 May 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Regulatory News:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200517005052/en/

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and ChemoCentryx, Inc., (NASDAQ: CCXI) today announced topline data from a forty-six (46) patient phase-II dose-ranging trial in the orphan kidney disorder, primary Focal Segmental Glomerulosclerosis (FSGS). The LUMINA-1 trial tested CCX140, an orally-administered selective inhibitor of the chemokine receptor known as CCR2, in primary FSGS subjects. In the study, CCX140 did not demonstrate a meaningful reduction in proteinuria relative to the control group after 12 weeks of blinded treatment.

Stefan Schulze, Chief Executive Officer Vifor Pharma Group comments, “Unfortunately, the results of the phase-II LUMINA-1 trial are not what we have hoped for in t ... Read more »

Update brought to you by MEMS – A Choueiri Group Brand